(Q40905275)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

24 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR. (English)

1 reference

24 September 2017

0 references

6

C H Gelband

0 references

author name string

H Wang

1

1 reference

24 September 2017

P Y Reaves

2

1 reference

24 September 2017

M L Gardon

3

1 reference

24 September 2017

K Keene

4

1 reference

24 September 2017

D S Goldberg

5

1 reference

24 September 2017

M J Katovich

7

1 reference

24 September 2017

M K Raizada

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

35

1 reference

24 September 2017

issue

1 Pt 2

1 reference

24 September 2017

page(s)

202-208

1 reference

Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension

24 September 2017

cites work

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1161/01.HYP.33.1.360

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Angiotensin II receptor pharmacology and AT1-receptor blockers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Coronary endothelial dysfunction in the hypertensive patient: from myocardial ischemia to heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Hypertension and the renin-angiotensin system--evidence from genetic and transgenic studies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Antihypertensive drugs and the nervous system: ACE-inhibitors restore oscillatory potentials in hypertensives

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Highly efficient germ-line transmission of proviral insertions in zebrafish

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Angiotensin II in central nervous system physiology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy

2 references

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.95.5.2664

Association of thrombocytopenia with the use of intra-aortic balloon pumps

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

ACE inhibitors in heart failure: prospects and limitations

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

The renin-angiotensin system and its receptors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Local renin-angiotensin systems

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1161/01.HYP.35.1.202

Identifiers

DOI

10.1161/01.HYP.35.1.202

1 reference

24 September 2017

1 reference